Genomic analyses have shown that the majority of grade II and III diffuse astrocytomas, IDH-wild-type, harbor genomic alterations and clinical outcomes akin to primary glioblastoma, grade IV [23]. The gene discussed is IDH1; the disease is diffuse astrocytoma.